Kuangli Bio-Tech Holdings Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 104.5 million compared to TWD 61.99 million a year ago. Net loss was TWD 8.8 million compared to TWD 25.22 million a year ago. Basic loss per share from continuing operations was TWD 0.15 compared to TWD 0.44 a year ago. Diluted loss per share from continuing operations was TWD 0.15 compared to TWD 0.44 a year ago. Basic loss per share was TWD 0.15 compared to TWD 0.44 a year ago. Diluted loss per share was TWD 0.15 compared to TWD 0.44 a year ago.
For the six months, sales was TWD 159.87 million compared to TWD 122.11 million a year ago. Net loss was TWD 35.04 million compared to TWD 53.93 million a year ago. Basic loss per share from continuing operations was TWD 0.61 compared to TWD 0.97 a year ago. Diluted loss per share from continuing operations was TWD 0.61 compared to TWD 0.97 a year ago. Basic loss per share was TWD 0.61 compared to TWD 0.97 a year ago. Diluted loss per share was TWD 0.61 compared to TWD 0.97 a year ago.